Clinical trial Recruiting at 10 sites Observational Ages 18 and up

Seeing Diabetes Clearly: multi-organ MRI of organ health in adults with type 2 diabetes

Official title: UK Imaging Diabetes Study Seeing Diabetes Clearly

Run by Perspectum · NCT05057403 · Data updated 2026-11-12

This project will use a detailed abdominal and multi-organ MRI plus blood and urine tests to see if imaging measurements can predict future health events in adults with type 2 diabetes who have not had heart disease.

More Type2 Diabetes trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorPerspectum
Industry-sponsored
Locations12 sites (Didcot, Oxfordshire and 11 other locations)
StatusRecruiting
StartedMay 30, 2022
Main results expectedJune 2034
Study endsJune 2034
Registry record updatedDecember 5, 2025
Trial IDNCT05057403 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with type 2 diabetes, no history of cardiovascular events in the prior 12 months, and who can safely undergo MRI are ideal candidates.

Probably not a fit

People with recent cardiovascular events, standard MRI contraindications (for example pacemaker, pregnancy, severe claustrophobia), known significant liver or renal structural disease, or alcohol dependency are not eligible and are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational cohort carried out at multiple UK sites where participants undergo one baseline visit with medical history, anthropometrics and blood/urine sampling, and a second visit for a multiparametric multi-organ MRI scan within 28 days. No change to standard care is made; the MRI and biomarker data are collected once and linked to routine NHS medical records for up to five years to capture hospital admissions and mortality. The aim is to correlate MRI-derived organ health metrics with later clinical events to characterise disease progression. Enrollment is limited to adults with type 2 diabetes without a recent cardiovascular event and who can safely undergo MRI.

Why it matters

Potential benefit: If successful, MRI-derived markers could help identify people with type 2 diabetes at higher risk of complications earlier, enabling closer monitoring or targeted prevention.

How similar studies have gone: Previous imaging work has linked individual MRI measures (such as liver fat and cardiac imaging) to metabolic risk, but using a coordinated multi-organ MRI to predict long-term clinical events in type 2 diabetes is relatively novel and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female at least 18 years of age and diagnosed with type 2 diabetes, with or without diabetic retinopathy.
* Participant willing and able to give informed consent for participation in the study.

Exclusion Criteria:

In 12 months prior to consent, evidence of existing cardiovascular event defined as at least one of:

* myocardial infarction
* ischaemic stroke
* hospital admission/discharge for unstable angina
* heart surgery
* unstable angina
* transient ischemic attack
* The participant may not enter the study if they have any contraindication to magnetic resonance imaging (standard MR exclusion criteria including pregnancy, extensive tattoos, pacemaker, shrapnel injury, severe claustrophobia).
* Patients with known autoimmune hepatitis, viral hepatitis, Wilson's disease or known significant structural renal tract abnormality.
* Patients with known alcohol dependency.
* Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the participant's ability to participate in the study

Where it's running

  • Woodlands Medical Centre
    Didcot, Oxfordshire, United Kingdom
    Recruiting
  • Eynsham Medical Centre
    Eynsham, Oxfordshire, United Kingdom
    Recruiting
  • White Horse Medical Practice
    Farringdon, Oxfordshire, United Kingdom
    Recruiting
  • Windrush Medical Practice
    Witney, Oxfordshire, United Kingdom
    Recruiting
  • The House Partnership
    Redhill, Surrey, United Kingdom
    Recruiting
  • University Hospitals of Liverpool Group
    Liverpool, United Kingdom
    Recruiting
Show 6 more locations
  • The Manor Group
    Oxford, United Kingdom
    Recruiting
  • Hedena Health
    Oxford, United Kingdom
    Recruiting
  • St Bartholomew and Hollow Way Medical Practice
    Oxford, United Kingdom
    Recruiting
  • Oxford Community Diagnostic centre
    Oxford, United Kingdom
    Recruiting
  • Swansea Bay University Health Board
    Baglan, Swansea, United Kingdom
    Not yet recruiting
  • Moorfields Eye Hospital NHS Foundation Trust
    London, United Kingdom
    Enrolling by invitation

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.